WHO approves Sinovac COVID-19 vaccine

Tuesday, 1 June 2021 19:34

By Reuters

The World Health Organisation (WHO) has approved a COVID-19 vaccine made by Sinovac Biotech for emergency use listing.

It's the second Chinese-produced shot to get its endorsement, a WHO statement said on Tuesday.

WHO emergency listing is a signal to national regulators on a product's safety and efficacy.

It would also allow the shot to be included in COVAX, the global programme to provide vaccines mainly for poor countries, which currently faces major supply problems.

In a statement, the independent panel of experts said it recommended Sinovac's vaccine for adults over 18, with a second dose 2-4 weeks later.

There was no upper age limit as data suggested it is likely to have a protective effect in older people.

More from International News

Israeli attacks on Gaza killed 60 people in 24 hours

Israeli occupation forces committed multiple massacres against families in the Gaza Strip over the past 24 hours, resulting in the killing of at least 60 Palestinians and the injury of 162 others, according to medical reports.
Trump fires National Security Agency director

U.S. President Donald Trump fired General Timothy Haugh as director of the National Security Agency on Thursday, according to two officials familiar with the decision, and congressional Democrats denounced the removal of the nonpartisan official from a top security post.
Israel steps up Syria strikes, says Turkey aims for 'protectorate'

Israel stepped up airstrikes on Syria, declaring the attacks a warning to the new rulers in Damascus as it accused their ally Turkey of trying to turn the country into a Turkish protectorate.
US sending Israel 20,000 assault rifles that Biden delayed

The Trump administration moved forward with the sale of more than 20,000 US-made assault rifles to Israel last month, according to a document seen by Reuters, pushing ahead with a sale that the administration of former president Joe Biden had delayed.